← All FR Documents
Notice

Foreign-Trade Zone (FTZ) 189, Notification of Proposed Production Activity; Grand River Aseptic Manufacturing; (Pharmaceutical Products); Caledonia and Grand Rapids, Michigan

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Commerce Department, Foreign-Trade Zones Board. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-18131
TypeNotice
PublishedSep 19, 2025
Effective Date-
RIN-
Docket IDB-44-2025
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

⏳ Requirements Extraction Pending

This document's regulatory requirements haven't been extracted yet. Extraction happens automatically during background processing (typically within a few hours of document ingestion).

Federal Register documents are immutable—once extracted, requirements are stored permanently and never need re-processing.

Full Document Text (260 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF COMMERCE <SUBAGY>Foreign-Trade Zones Board</SUBAGY> <DEPDOC>[B-44-2025]</DEPDOC> <SUBJECT>Foreign-Trade Zone (FTZ) 189, Notification of Proposed Production Activity; Grand River Aseptic Manufacturing; (Pharmaceutical Products); Caledonia and Grand Rapids, Michigan</SUBJECT> Kent-Ottawa-Muskegon Foreign-Trade Zone Authority, grantee of FTZ 189, submitted a notification of proposed production activity to the FTZ Board (the Board) on behalf of Grand River Aseptic Manufacturing (GRAM) for GRAM's facilities in Caledonia and Grand Rapids within Subzone 189H. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on September 12, 2025. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website—accessible via <E T="03">www.trade.gov/ftz</E> . The proposed finished products are atigotatug—nivolumab 420mg and 360mg/vials (70mg and 60mg/mL) and atigotatug—nivolumab 560mg and 480mg/vials (70mg and 60mg/mL) (duty-free). The proposed foreign-status material is nivolumab (180mg/mL) active pharmaceutical ingredient (duty-free). Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary and sent to: <E T="03">ftz@trade.gov</E> . The closing period for their receipt is October 27, 2025. A copy of the notification will be available for public inspection in the “Online FTZ Information System” section of the Board's website. For further information, contact Christopher Wedderburn at <E T="03">Chris.Wedderburn@trade.gov</E> . <SIG> <DATED>Dated: September 15, 2025.</DATED> <NAME>Elizabeth Whiteman,</NAME> Executive Secretary. </SIG> <FRDOC>[FR Doc. 2025-18131 Filed 9-18-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.